A. Pettersen

发表

Novel biomolecules of ageing, sex differences and potential underlying mechanisms of telomere shortening in coronary artery disease

H. Arnesen, T. Opstad, I. Seljeflot, 2019, Experimental Gerontology.

Markers of hypercoagulability in CAD patients. Effects of single aspirin and clopidogrel treatment

H. Arnesen, T. Opstad, I. Seljeflot, 2012, Thrombosis Journal.

High On-Aspirin Platelet Reactivity and Clinical Outcome in Patients With Stable Coronary Artery Disease: Results From ASCET (Aspirin Nonresponsiveness and Clopidogrel Endpoint Trial)

H. Arnesen, I. Seljeflot, M. Abdelnoor, 2012, Journal of the American Heart Association.

A brief review on high on-aspirin residual platelet reactivity.

H. Arnesen, I. Seljeflot, A. Pettersen, 2015, Vascular pharmacology.

The Influence of Tissue Factor and Tissue Factor Pathway Inhibitor Polymorphisms on Thrombin Generation in Stable Coronary Artery Disease

H. Arnesen, T. Opstad, I. Seljeflot, 2011, Pathophysiology of Haemostasis and Thrombosis.

Cigarette smoking represses expression of cytokine IL-12 and its regulator miR-21-An observational study in patients with coronary artery disease.

H. Arnesen, T. Opstad, I. Seljeflot, 2017, Immunobiology.

Complement Activation in Association with Markers of Neutrophil Extracellular Traps and Acute Myocardial Infarction in Stable Coronary Artery Disease

H. Arnesen, T. Opstad, I. Seljeflot, 2020, Mediators of inflammation.

vWF/ADAMTS13 is associated with on-aspirin residual platelet reactivity and clinical outcome in patients with stable coronary artery disease

H. Arnesen, I. Seljeflot, A. Pettersen, 2017, Thrombosis Journal.

TERT and TET2 Genetic Variants Affect Leukocyte Telomere Length and Clinical Outcome in Coronary Artery Disease Patients—A Possible Link to Clonal Hematopoiesis

H. Arnesen, T. Opstad, S. Solheim, 2022, Biomedicines.

Combined Elevated Levels of the Proinflammatory Cytokines IL-18 and IL-12 Are Associated with Clinical Events in Patients with Coronary Artery Disease: An Observational Study.

H. Arnesen, T. Opstad, I. Seljeflot, 2016, Metabolic syndrome and related disorders.

Genetic variation, gene-expression and circulating levels of matrix metalloproteinase-9 in patients with stable coronary artery disease.

H. Arnesen, T. Opstad, I. Seljeflot, 2012, Clinica chimica acta; international journal of clinical chemistry.

The MMP-9 -1562 C/T Polymorphism in the Presence of Metabolic Syndrome Increases the Risk of Clinical Events in Patients with Coronary Artery Disease

H. Arnesen, T. Opstad, I. Seljeflot, 2014, PloS one.

The Co-Existence of the IL-18+183 A/G and MMP-9 -1562 C/T Polymorphisms Is Associated with Clinical Events in Coronary Artery Disease Patients

H. Arnesen, T. Opstad, I. Seljeflot, 2013, PloS one.

Markers of neutrophil extracellular traps are associated with adverse clinical outcome in stable coronary artery disease

H. Arnesen, T. Opstad, S. Solheim, 2018, European journal of preventive cardiology.

Unstable angina, stroke, myocardial infarction and death in aspirin non‐responders. A prospective, randomized trial. The ASCET (ASpirin non‐responsiveness and Clopidogrel Endpoint Trial) design

H. Arnesen, I. Seljeflot, M. Abdelnoor, 2004, Scandinavian cardiovascular journal : SCJ.

Fractalkine and its receptor (CX3CR1) in patients with stable coronary artery disease and diabetes mellitus.

H. Arnesen, T. Opstad, I. Seljeflot, 2012, Metabolic syndrome and related disorders.

Genetic Variation in ADAMTS13 is Related to VWF Levels, Atrial Fibrillation and Cerebral Ischemic Events

H. Arnesen, T. Opstad, I. Seljeflot, 2022, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

investigationGender differences of polymorphisms in the TF and TFPI genes , as related to phenotypes in patients with coronary heart disease and type-2 diabetes

H. Arnesen, T. Opstad, I. Seljeflot, 2015 .

Gender differences of polymorphisms in the TF and TFPI genes, as related to phenotypes in patients with coronary heart disease and type-2 diabetes

H. Arnesen, T. Opstad, I. Seljeflot, 2010, Thrombosis journal.

Original clinical investigation Gender differences of polymorphisms in the TF and TFPI genes, as related to phenotypes in patients with coronary heart disease and type-2 diabetes

H. Arnesen, T. Opstad, I. Seljeflot, 2010 .

No difference in the effects of clopidogrel and aspirin on inflammatory markers in patients with coronary heart disease

H. Arnesen, S. Solheim, I. Seljeflot, 2006, Thrombosis and Haemostasis.

Novel biomolecules of ageing, sex differences and potential underlying mechanisms of telomere shortening in coronary artery disease

H. Arnesen, T. Opstad, I. Seljeflot, 2019, Experimental Gerontology.

Markers of endothelial and platelet activation are associated with high on-aspirin platelet reactivity in patients with stable coronary artery disease.

H. Arnesen, T. Opstad, I. Seljeflot, 2012, Thrombosis research.

The influence of CYP 2C19*2 polymorphism on platelet function testing during single antiplatelet treatment with clopidogrel

H. Arnesen, T. Opstad, I. Seljeflot, 2011, Thrombosis journal.

Circulating levels of IL-18 are significantly influenced by the IL-18 +183 A/G polymorphism in coronary artery disease patients with diabetes type 2 and the metabolic syndrome: an Observational Study

H. Arnesen, T. Opstad, I. Seljeflot, 2011, Cardiovascular diabetology.

Poster session 2

Hugo A. Katus, V. V. Miroshnikova, Paolo Dario, 2004, EP Europace.

Gender differences of polymorphisms in the TF and TFPI genes, as related to phenotypes in patients with coronary heart disease and type-2 diabetes

H. Arnesen, T. Opstad, I. Seljeflot, 2010 .

P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events.

Deepak L. Bhatt, H. Schunkert, A. Kastrati, 2023, Journal of the American College of Cardiology.

Circulating levels of the terminal complement complex are associated with hypercoagulability in patients with stable coronary artery disease.

H. Arnesen, I. Seljeflot, T. Tønnessen, 2020, Thrombosis research.

The NLRP3 Genetic Variant (rs10754555) Reduces the Risk of Adverse Outcome in Middle-Aged Patients with Chronic Coronary Syndrome

T. Opstad, S. Solheim, I. Seljeflot, 2022, Journal of immunology research.

Cigarette smoking represses expression of cytokine IL-12 and its regulator miR-21-An observational study in patients with coronary artery disease.

T. Opstad, I. Seljeflot, A. Pettersen, 2017, Immunobiology.

A brief review on high on-aspirin residual platelet reactivity.

H. Arnesen, I. Seljeflot, A. Pettersen, 2015, Vascular pharmacology.